Blog
Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety
Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety
EQS-News: Daldrup & Söhne AG significantly increases EBIT result in H1 2022
EQS-News: Daldrup & Söhne AG significantly increases EBIT result in H1 2022
IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure
IGEA Pharma N.V.: IGEA to get SIX approval to the semi-annual 2022 report disclosure
FITCH ASSIGNS AN INVESTMENT GRADE BBB- RATING TO KAUFMAN & BROAD
FITCH ASSIGNS AN INVESTMENT GRADE BBB- RATING TO KAUFMAN & BROAD
EQS-Adhoc: ROY Asset Holding SE: New management
EQS-Adhoc: ROY Asset Holding SE: New management
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
WICKES GROUP PLC: Director / PDMR Shareholding
WICKES GROUP PLC: Director / PDMR Shareholding
EQS-News: Cryptology’s estimated NAV per share as of 28/09/2022 is €5.08
EQS-News: Cryptology’s estimated NAV per share as of 28/09/2022 is €5.08
Fuller, Smith & Turner PLC: Holding(s) in Company
Fuller, Smith & Turner PLC: Holding(s) in Company
Directorate Change
Directorate Change
EQS-Adhoc: Petro Welt Technologies AG: Supervisory Board approves the Management Board’s decision to terminate business activities in Oman
EQS-Adhoc: Petro Welt Technologies AG: Supervisory Board approves the Management Board’s decision to terminate business activities in Oman
Correction: Director/PDMR Shareholding
Correction: Director/PDMR Shareholding
EQS-Adhoc: VARTA AG: Herbert Schein resigns as Chairman of the Executive Board with immediate effect, but remains on the Executive Board until 31 December 2022
EQS-Adhoc: VARTA AG: Herbert Schein resigns as Chairman of the Executive Board with immediate effect, but remains on the Executive Board until 31 December 2022
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - Maitland Institutional Services Limited: Re Attraqt Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Attraqt Group plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc


